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Visual Analogue Scale (VAS)Abstract Objective: This prospective randomized, double blind controlled study was designed to
evaluate the effect of Intravenous (i.v) magnesium sulfate infusion on attenuation of tourniquet
induced hypertension (TIH) and tourniquet pain and also its effect on postoperative analgesia in
patients undergoing arthroscopic knee surgery under epidural anesthesia.
Patients and methods: Seventy ASA I and II patients were scheduled for arthroscopic knee surgery
with tourniquet under epidural anesthesia. Patients were allocated randomly into two equal groups
(n= 35): Magnesium (Mg group) received a bolus dose of IV magnesium sulfate 30 mg/kg in 50 ml
saline over 10 min, followed by infusion 10 mg/kg/h and control group received iv saline. Systolic
and Diastolic blood pressure (SBP, DBP) and Heart rate (HR) were measured at baseline (before
anesthesia), after epidural anesthesia, then every 10 min after the tourniquet inﬂation, and 1, 5, 10,
and 30 min after deﬂation with recording incidence of (TIH), tourniquet pain, and total iv fentanyl
consumption (was given iv 1 ug/kg with tourniquet pain); postoperative Visual Analogue Scale
(VAS) score was assessed at 1, 2, 4, 8, 12, 18, and 24 h, postoperative pethidine consumption (given
iv 0.5 mg/kg if VAS > 3) was recorded, and serum magnesium was measured preoperatively and at
6 and 24 h postoperatively.
Results: SBP, DBP and HR were signiﬁcantly higher in the control group than in the Mg group
(p< 0.001) after 50 min of inﬂation. The number of patients who developed TIH and tourniquet
pain was signiﬁcantly lower in Mg group compared to control group 3(8.57%) vs 12(34.28%)
(p< 0.05), with signiﬁcantly shorter time to feel pain in control group 48 ± 8 min versus 71
± 7 min (p< 0.001). Intraoperative fentanyl requirements were signiﬁcantly higher in control
group compared to Mg group (p< 0.001). Mg group had signiﬁcantly lower postoperative VAS
scores and pethidine consumption (p< 0.001) and signiﬁcantly longer time to ﬁrst request ofd pain in
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arthroscopic knee surgery patients under epipostoperative analgesia compared to control group (p< 0.001). Postoperative serum magnesium
was signiﬁcantly higher in Mg group at 6 h postoperative (p< 0.001).
Conclusion: In patients undergoing arthroscopic knee surgery under epidural anesthesia, IV mag-
nesium sulfate in a dose of 30 mg/kg, followed by 10 mg/kg/h infused before tourniquet inﬂation
could reduce TIH, and tourniquet pain with reduction in intraoperative IV fentanyl and postoper-
ative pethidine requirements.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Management of patients undergoing surgery with tourniquet
application as joint replacement or other lower limb surgery
becomes challenging during general or regional anesthesia.
Although pneumatic tourniquet may be helpful to decrease
intraoperative bleeding and maintain dry surgical ﬁeld, on
the other hand this is associated with some side effects that
occur during inﬂation as well as after deﬂation [1]. The most
common complication after tourniquet inﬂation is tourniquet
pain which initiates tourniquet-induced hypertension (TIH).
Also marked hypotension can occur after tourniquet deﬂation
due to redistribution of the circulating blood back into the
limb and post-ischemic reactive hyperemia with release of
accumulated metabolites into the circulation leading to
hypotension and metabolic changes [2].
With prolonged tourniquet inﬂation during general anes-
thesia patients may develop hypertension and tachycardia that
may be due to activation of the sympathetic nervous system in
response to pain which is difﬁcult to relief by narcotics and dif-
ferent analgesics. Patients under regional anesthesia complain
of extreme discomfort from prolonged tourniquet inﬂation
[3]. The tourniquet pain, is described as severe, dull, aching
sensation at the site of the tourniquet application, and it can
develop despite adequate anesthesia and analgesia during sur-
gery. It is difﬁcult to treat tourniquet pain and hypertension
(TIH) [4].
Tourniquet-induced hypertension (TIH) is generally
deﬁned as a progressive increase of more than 30% of systolic
blood pressure that may be observed 30–60 min after tourni-
quet inﬂation; the exact mechanism of its development is
unknown but most probably related to tourniquet pain [5]. It
is thought that prolonged ﬁring of unmyelinated slow-
conducting c-ﬁbers is most probably responsible for
tourniquet-induced pain and hypertension due to release of
glutamate which acts on N-methyl-D-aspartic acid (NMDA)
receptors in the spinal cord [6].
Various NMDA receptor antagonists were used to manage
tourniquet pain and TIH [5,7–9]. Other drugs and methods
were used to reduce tourniquet effects such as the use of regio-
nal anesthesia, intravenous (IV) opioids, paracetamol, gaba-
pentin, non-steroidal anti-inﬂammatory drugs (NSAIDs),
melatonin and clonidine which has been reported to depress
nerve action potentials in c-ﬁbers [10].
Regional anesthetic techniques are most commonly used
for orthopedic surgery as they are safe, effective and can pro-
vide prolonged postoperative analgesia [11].
Magnesium sulfate is a NMDA receptor antagonist, and it
has antinociceptive effects that had been estimated in animal
and human models of pain [12]. Some studies assessed theLotfy E Evaluation of eﬀect of intraven
dural anesthesia, Egypt J Anaesth (201analgesic effect of magnesium sulfate with general anesthesia
and proved to be effective in lowering intraoperative anesthetic
and analgesic requirements as well as postoperative require-
ments of opioid analgesics [12,13]. Few studies have evaluated
the effect of magnesium sulfate infusion during regional anes-
thesia [14,15].
The aim of this prospective randomized, placebo-
controlled, double blind study was to evaluate the efﬁcacy of
IV magnesium sulfate infusion for attenuation of tourniquet
induced hypertension (TIH) and tourniquet pain as well as
its effect on postoperative analgesia in patients undergoing
arthroscopic knee surgery under epidural anesthesia.
2. Patients and methods
This prospective randomized, double-blind, placebo-
controlled study was conducted at the Department of Ortho-
pedic Surgery in Kaser El Aini Hospital from October 2014
to October 2015. After obtaining institutional ethical commit-
tee approval and an informed written consent was signed by
each patient included in the study, the study started and
involved 70 patients aged 20–60 years of American Society of
Anesthesiology (ASA) class I or II of both sexes who were
undergoing arthroscopic knee surgery requiring thigh tourni-
quet for at least one hour under epidural anesthesia.
Exclusion criteria were patients with known hypersensitiv-
ity to local anesthetics, local infection in the lumbar region,
bleeding diathesis, a history of hypertension, renal, hepatic,
respiratory or cardiac diseases and varying degree of heart
block, as well as neurologic, neuromuscular or psychiatric dis-
eases. Also patients with history of allergy to the study drug,
and patients treated with calcium channel blockers or magne-
sium were not included in the study.
Prior to surgery, patients had a full explanation of the
epidural technique as well as the visual analogue scale (VAS;
0: no pain; 10: worst pain), the method of postoperative anal-
gesia and to demand rescue analgesic at the onset of break-
through pain (VAS > 3).
Patients were randomly assigned to two equal groups (35
patients in each group). Randomization was done using
computer-generated number table of random numbers and
conducted using sequentially numbered, opaque and sealed
envelope (SNOSE). The two groups were as follows:
– Magnesium group (Mg group) (n= 35): received IV mag-
nesium sulfate bolus dose of 30 mg/kg in 50 ml saline over
10 min, followed by iv infusion of 10 mg/kg/h in 100 ml sal-
ine before tourniquet inﬂation and the iv infusion continued
throughout surgery. Magnesium infusion stopped at the
onset of tourniquet deﬂation.ous Magnesium Sulfate infusion on tourniquet induced hypertension and pain in
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10 min, followed by iv saline infusion (the same volume as
Mg group) continued throughout surgery and stopped at
the onset of tourniquet deﬂation.
The patients, investigators, anesthesiologists and the sur-
geons were blinded to the given infusion. The infusions were
prepared preoperatively by an anesthesiologist unaware of
group assignments using identical 100-mL infusion syringe
pump. Standard protocol was followed for all patients
throughout the study.
In the operation theater intravenous (i.v) access with 18G
cannula was established and preloading with Ringer Lactate
was carried out standard monitoring including the following:
Electrocardiogram (ECG), pulse oximetry and noninvasive
arterial blood pressure monitors were applied, and a baseline
heart rate, blood pressure (systolic, diastolic) and peripheral
oxygen saturation were recorded. Each patient received
10 ml/kg lactated Ringer’s solution at body temperature as
ﬂuid preload over approximately 20–30 min before epidural
and 6–8 ml/kg/h after epidural anesthesia throughout surgery.
Another intravenous access was established using 18-gauge
cannula and infusion of the study drugs was given as the fol-
lowing: before the insertion of epidural catheter, the patients
in the ﬁrst group (magnesium group) received IV magnesium
sulfate bolus dose of 30 mg/kg in 50 ml saline over 10 min
via a syringe infusion pump, followed by iv infusion of
10 mg/kg/h in 100 ml saline (started after the insertion of
epidural catheter), and the second group (control group)
received iv 50 ml saline over 10 min (before the insertion of
epidural catheter), followed by iv saline infusion (the same vol-
ume as Mg group) (started after the insertion of epidural
catheter), Magnesium or saline iv infusion stopped at the onset
of tourniquet deﬂation.
Patients of both groups received epidural anesthesia under
complete aseptic conditions. The epidural space was identiﬁed
at the level of L3-L4 or L4-L5 interspace with 18 gauge Tuohy
needle. The needle was inserted with the aperture directed
cephalad. The epidural space was deﬁned by loss of resistance
technique using saline and correct position was conﬁrmed by
injection of lidocaine 2% (3 ml) with epinephrine in concentra-
tion of 1:200,000. The epidural catheter 20 G was inserted,
advanced 3–5 cm into the epidural space and proper ﬁxation
and conﬁrmation of its position were performed after negative
aspiration of CSF and blood to rule out accidental intrathecal
or intravascular placement. All patients received 0.5% Bupiva-
caine, 1 ml/segment was given in the epidural catheter incre-
mentally over 5 min period and the patient was repositioned
supine. Sensory block was assessed by using loss of tempera-
ture sensation with an ice cube every 5 min for ﬁrst 30 min.
The level to be blocked was up to T10, and an additional
5 mL of local anesthetic added after 10 min if the block height
was below T10.
Motor block was evaluated using a modiﬁed Bromage scale
[16] (0: no motor block, 1: inability to raise extended legs, 2:
inability to ﬂex knees, 3: inability to ﬂex ankle joints).
The pneumatic tourniquet inﬂated after epidural anesthesia
(when sensory level was ﬁxed at T10 and modiﬁed Bromage
score of 3), and it was placed on the affected lower limb over
a cotton layer after elevation of the limb; then, exsanguination
was done using crepe bandage. The pneumatic tourniquet
inﬂation pressure was 300 mmHg. After tourniquet inﬂationPlease cite this article in press as: El Shal SM, Lotfy E Evaluation of eﬀect of intraven
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releasing the tourniquet, a 200-mL bolus of lactated Ringer’s
solution was infused rapidly.
During the study period arterial blood pressure (SBP,
DBP), heart rate (HR), and oxygen saturation were monitored
continuously and recorded at the following time points: upon
arrival to operating room before anesthesia and before starting
infusion of the study drug (baseline), and after epidural anes-
thesia and then every 10 min after tourniquet inﬂation and at
1, 5, 10 and 30 min after tourniquet deﬂation. The number
of patients who developed TIH (which is deﬁned by an
increase in SBP > 30% of the baseline value) was also
recorded.
Assessment of intraoperative pain scores was made on the
basis of the visual analogue scale (VAS) measured every
20 min after tourniquet inﬂation till 5 min after deﬂation.
When patients complained of pain during surgery, he was
asked to describe the nature of that pain it was recorded as
tourniquet pain if it was not related to the surgical ﬁeld and
was described as a dull, tight, aching sensation at the area of
the tourniquet application. At the onset of tourniquet pain,
1 lg/kg of intravenous (iv) fentanyl was given if VAS > 3,
with recording the total iv fentanyl consumption, the onset
time of pain, and the level of sensory block was assessed by
pin prick method by an observer unaware of the patient’s
group.
In both groups any hemodynamic changes were recorded:
hypotension deﬁned as SBP <90 mmHg or >20% decreases
in baseline values, and it was treated with a bolus of 200 mL
of Lactated Ringer’s solution. If hypotension persisted for
>5 min, 5 mg ephedrine was given intravenously. Bradycardia
deﬁned as heart rate <50 beat/min was treated with 0.3 mg IV
atropine (can be repeated if required). Tachycardia was deﬁned
as heart rate >100 or HR >20% of the baseline value, and
TIH was deﬁned as increase in SBP >30% of the baseline
value. Iv fentanyl 1 lg/kg was given to manage TIH with
recording of number of patients who developed TIH and the
total amount of fentanyl was given intraoperatively. If there
was no response iv esmolol 25 mg increments were given.
The epidural catheter was removed at the end of surgery,
diclofenac sodium 75 mg intramuscularly was given, and
patients were transferred to the post anesthesia care unit
(PACU) with continuous assessment of BP, HR, SPO2, VAS
and any side effects (nausea, vomiting, and shivering). Rescue
medication was administered after any untoward event. Respi-
ratory depression (respiratory rate < 9/min or SpO2 < 92%)
was treated by supplemental oxygen. Heart rate < 50 bpm
was controlled by 0.3 mg IV atropine, and nausea and vomit-
ing were treated with 4 mg IV ondansetron. Postoperative
sedation was monitored and recorded at PACU by using a
4-point rating scale [17] (Grade 0: awake and alert; 1: mildly
sedated, easily aroused; 2: moderately sedated, aroused by
shaking; 3: deeply sedated, difﬁcult to be aroused by physical
stimulation). All assessments were carried out by another anes-
thesiologist not involved in the intraoperative care of the
patients and blinded to the group assignment.
Patients were discharged to the ward when all hemody-
namic variables were stable with completely resolved motor
block, satisfactory pain relief (VAS < 3), and the absence of
nausea and vomiting.
The postoperative pain was assessed by VAS at 1, 2, 4, 8,
12, 18 and 24 h after surgery. Postoperative analgesia wasous Magnesium Sulfate infusion on tourniquet induced hypertension and pain in
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4 S.M. El Shal, E. Lotfyprovided by Pethidine 0.5 mg/kg IV if VAS > 3 or if the
patient complained of pain and asked for analgesia in between
VAS assessment visits considering at least 4 h after the last
dose. The time for the ﬁrst analgesic requirement and the total
pethidine consumption in the ﬁrst 24 h were recorded.
Serum Magnesium level was assessed before magnesium
infusion (baseline) and then at 6 and 24 h postoperatively.
Primary outcome measure of the study was to assess the
incidence of TIH in both groups.
Secondary outcome measures were to assess frequency of
tourniquet pain, onset of tourniquet pain, total iv fentanyl
consumption, postoperative VAS, the duration of effective
analgesia (the time interval between the end of study drug infu-
sion and the ﬁrst request for analgesic), total pethidine con-
sumption and postoperative complaints (nausea, vomiting,
respiratory depression, and shivering). Also the preoperative
and postoperative serum magnesium was assessed.
2.1. Statistical analysis
The required sample size was calculated using IBM SPSS
SamplePower (IBM Corp., Armonk, New York, USA).
Based on previous study with detection of a reduction inAssessment  for e
Randomiz
Allocated to intervention(n=35)
Received allocation to  intervention(saline 
infusion) (n=35)
Did not receive allocation to  intervention(n=0)
Excluded(n=0)
Lost to follow up(n=0)
Discontinued intervention(n=0)
Analysed (n=35)
Excluded from analysis (n=0)
Alloca
Follow
Analysis
Figure 1 CONSORT diagram showing the ﬂow o
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power set at 80% and a error level ﬁxed at 0.05, it was esti-
mated that a sample of 28 patients in each group is required
to detect signiﬁcant decrease in incidence of TIH. The sample
size was increased to 35 patients in each group enrolled to
compensate for any dropouts during the study. Data were
described in terms of mean ± standard deviation (±SD) or
frequencies and percentages as appropriate. Comparison of
numerical variables between the two groups was done using
Student t test for independent samples for normally distributed
data and Mann Whitney-U test if data are not normally dis-
tributed. For comparing categorical data, Chi square (or Fish-
er’s exact) test was used. A p value < 0.05 was considered
statistically signiﬁcant. All statistical calculations were done
using computer program SPSS (Statistical Package for the
Social Science; SPSS Inc., Chicago, IL, USA) version 15.
3. Results
Fig. 1 shows the CONSORT diagram for the ﬂow of partici-
pants through each stage of the present study.
There were no signiﬁcant differences between the two
groups with respect to patients’ characteristics, duration ofligibility( n=70)
ed(n= 70)
Allocated to intervention(n=35)
Received allocation to  intervention ( Mg sulphate 
infusion)(n=35) 
Did not receive allocation to  intervention(n=0)
Lost to follow up(n=0)
Discontinued intervention(n=0)
Analysed (n=35)
Excluded from analysis (n=0)
tion
 up
Enrollment
f participants through each stage of the study.
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(p> 0.05) (Table 1).
The two groups were similar in the maximal dermatome
height achieved (T8-10). No difference in the quality of sensory
and motor block before and during surgery was noted between
groups (the pneumatic tourniquet inﬂated after epidural anes-
thesia when sensory level ﬁxed at T10 and Bromage score of 3).
There was no statistical signiﬁcant difference between both
groups for their mean time required to achieve complete sen-
sory block up to the level of T-10 (10.59 ± 2.87 min in magne-
sium group versus 10.47 ± 2.93 min in the control group), and
time of motor block to Bromage Score-3 (19.39 ± 2.87 min in
magnesium group versus 20.45 ± 2.34 min in control group)
(p> 0.05).
Systolic and diastolic blood pressure values were compara-
ble in both groups at the baseline, after epidural induction of
anesthesia and after tourniquet inﬂation (Ti10-Ti40), but there
was signiﬁcant increase in SBP and DBP in the control group
compared to baseline value and to Mg group values at Ti50,
Ti60, Ti70 and Ti80 (p< 0.001). After tourniquet deﬂation
there was signiﬁcant reduction in mean SBP and DBP from
baseline values in both groups in the 1st and 5th min afterTable 1 Patient’s demographic and operative data.
Variables Magnesium
group n= 35
Control
group n= 35
Age (yrs) 44 ± 5 44 ± 6
Male/female (n) 19/16 17/18
Weight (kg) 70 ± 9 70 ± 8
Height (cm) 161 ± 6 163 ± 6
ASA (I/II) 14/21 16/19
Duration of surgery (min) 118 ± 7 119 ± 7
Duration of Tourniquet (min) 80 ± 8 80 ± 9
Baseline SBP (mmHg) 123 ± 8 122 ± 7
Baseline DBP (mmHg) 75 ± 7 76 ± 7
Baseline HR (beat/min) 78 ± 7 76 ± 7
Data are mean ± SD or numbers.
No statistically signiﬁcant differences between the two groups.
#* #*
Figure 2 Mean ± SD systolic blood pressure changes (mmHg) over
group =Magnesium group). Ti: min. after tourniquet inﬂation, Td: m
two groups (p< 0.001). #p< 0.001 compared to the baseline value in
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to baseline values at 10 and 30 min (Td10 and Td30) (Figs. 2
and 3).
Signiﬁcantly fewer patients that had TIH were observed in
Mg group compared to control group (3(8.57%) vs 12
(34.28%); (p< 0.05)). The number of patients required esmo-
lol was more in control group compared to Mg group (4
patients (11.42%) vs 1 patient (2.85%)) but there was no sta-
tistically signiﬁcant difference between both groups (p> 0.05).
Heart rate (HR) signiﬁcantly increased in control group
compared to baseline value and to Mg group measurements
from Ti60, Ti70 and Ti80 (p< 0.001). After tourniquet deﬂa-
tion there was comparable signiﬁcant increase from baseline
values of HR in both groups in the 1st and 5th min after deﬂa-
tion (Td1 and Td5) but both groups return to near baseline
values at 10 and 30 min (Td10 and Td30) Fig. 4.
The SpO2 was higher than 95% in all patients of the two
groups, either during surgery or in the PACU.
VAS scores for tourniquet pain were signiﬁcantly lower in
Mg group at 40, 60 and 80 min after tourniquet inﬂation and
5 min after deﬂation (Table 2). Signiﬁcantly fewer patients
complaining of tourniquet pain were observed in Mg group
compared to control group (3(8.57%) vs 12(34.28%);
p< 0.05), with signiﬁcantly shorter time to feel pain in the
control group (p< 0.001). The total dose of intraoperative
iv fentanyl was signiﬁcantly higher in control group compared
to Mg group (148 ± 12 vs. 74 ± 10; p< 0.001) (Table 2). The
level of sensory block at the onset of tourniquet pain was com-
parable in the two groups (T-10).
During the postoperative period, Mg group patients had
signiﬁcantly lower VAS scores after 1, 2, 4, 8, and 12 h
(p< 0.001). After 18 and 24 h VAS scores were comparable
(Fig. 5). Time to ﬁrst request of postoperative analgesia was
signiﬁcantly longer in Mg group compared to control group
(243 ± 20 min vs 150 ± 22 min) (p< 0.001). The cumulative
dose of rescue analgesia (Pethidine) used in the postoperative
24 h was signiﬁcantly lower in Mg group (p< 0.001) (Table 3).
No major complications were seen throughout the study
period and no patient needed any intervention due to periop-
erative respiratory problems. The frequency of postoperative
nausea and vomiting and sedation was comparable in both#*
#*
#
#
the study period in the studied groups (n= 35 in each group) (Mg
in. after tourniquet deﬂation. *Signiﬁcant difference between the
both groups.
ous Magnesium Sulfate infusion on tourniquet induced hypertension and pain in
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#*
##
#*
#* #*
Figure 3 Mean ± SD of diastolic blood pressure changes (mmHg) over the study period in the studied groups (n= 35 in each group)
(Mg group =Magnesium group). Ti: min. after tourniquet inﬂation, Td: min. after tourniquet deﬂation. *Signiﬁcant difference between
the two groups (p< 0.001). #p< 0.001 compared to the baseline value in both groups.
#*
#*
#*
#
#
Figure 4 Mean ± SD of heart rate changes (beats/min) over the study period in the studied groups (n= 35 in each group) (Mg
group =Magnesium group). Ti: min. after tourniquet inﬂation, Td: min. after tourniquet deﬂation. *Signiﬁcant difference between the
two groups (p< 0.001). #p< 0.001 compared to the baseline value in both groups.
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shivering (2.85% vs 28.57%) (p< 0.01) (Table 4).
Postoperative serum magnesium was signiﬁcantly higher in
Mg group at 6 h postoperatively (p< 0.001) and returned to
the normal values at 24 h (p= 0.224) (Table 5).4. Discussion
This study showed that IV magnesium sulfate bolus dose
(30 mg/kg), followed by (10 mg/kg/h) infusion before tourni-
quet inﬂation during knee surgery under epidural anesthesia
could decrease tourniquet-induced hypertension (TIH), and
lowered the frequency of tourniquet pain. Also postoperative
pain and analgesic consumption were reduced.
The exact mechanism of TIH is not clear but few theories
exist explaining the mechanism of TIH and tourniquet pain.
One of them suggested that the sympathetic activation due
to pain is the cause of TIH [4,7]. The other theory suggested
that the unmyelinated, slow C-ﬁbers that are normally inhib-
ited by large, fast, myelinated A ﬁbers mediate this pain caus-
ing hypertension [5].Please cite this article in press as: El Shal SM, Lotfy E Evaluation of eﬀect of intraven
arthroscopic knee surgery patients under epidural anesthesia, Egypt J Anaesth (201Approximately 30 min after tourniquet inﬂation, A-delta
ﬁbers are thought to be blocked before the C-ﬁbers which lead
to loss of conduction in these large A-delta ﬁbers and this
seems to take away the post-synaptic inhibition of C-ﬁbers
by the large ﬁbers. The skin under the inﬂated tourniquet pro-
vides the continuous stimulation of these C-ﬁbers [6]. Contin-
uous ﬁring of C-ﬁber nociceptors causes activation of NMDA
receptors in the dorsal horn of the spinal cord leading to cen-
tral sensitization. Associated increases in arterial pressure and
heart rate are considered as humoral responses to the pain
[5,6,19]. TIH is difﬁcult to be managed by antihypertensive
drugs but it subsides immediately after tourniquet deﬂation [5].
Some studies indicated that the NMDA receptor activation
produced increases in mean arterial pressure while the NMDA
receptor antagonism blocked the cardiovascular response in
animals [20].
Some NMDA receptor antagonists could attenuate
tourniquet-induced pain and hypertension under general anes-
thesia as reported in previous studies [5,8,9,21] as the NMDA
receptor antagonists could prevent central sensitization that
occurs due to peripheral nociceptive stimulation [19]. Tourni-
quet pain may occur during spinal or epidural anesthesiaous Magnesium Sulfate infusion on tourniquet induced hypertension and pain in
6), http://dx.doi.org/10.1016/j.egja.2016.08.022
Table 2 Intraoperative characteristics of tourniquet pain in
the studied groups.
Magnesium
group n= 35
Control group
n= 35
VAS score after inflation
20 min 1 (0–1) 1 (0–1)
40 min 1 (0–1)** 2 (0–3)
60 min 1 (0–2)** 3 (1–4)
80 min 2 (1–3)** 3 (2–5)
VAS score 5 min after
deﬂation
1 (0–1)** 2 (1–3)
Number of patients with
tourniquet pain
3 (8.57%)* 12 (34.28%)
Onset of tourniquet pain
(min)
71 ± 7** 48 ± 8
Total fentanyl requirement
(lg)
74 ± 10** 148 ± 12
P value < 0.05 is statistically signiﬁcant.
* P value < 0.05 in the Magnesium group compared to the
control group.
** P value < 0.001 in the Magnesium group compared to the
control group.
Table 3 Postoperative analgesic characteristics in the studied
groups.
Magnesium
group
Control
group
n= 35 n= 35
Total dose of pethidine in 24 h (mg) 96 ± 38** 143 ± 48
Time of ﬁrst dose of pethidine
required (min)
243 ± 20** 150 ± 22
Data are mean ± SD.
P value < 0.05 is statistically signiﬁcant.
** P value < 0.001 in the Magnesium group compared to the
control group.
Table 4 Frequency of postoperative side effects in the studied
groups.
Side eﬀect Magnesium group
n= 35
Control group
n= 35
Nausea and
vomiting
1 (2.85%) 2 (5.71%)
Sedation 2 (5.71%) 1 (2.85%)
Shivering 1 (2.85%)** 10 (28.57%)
Data are numbers of patients (%).
P value < 0.05 is statistically signiﬁcant.
** P value < 0.01 in the Magnesium group compared to the
control group.
Evaluation of effect of intravenous Magnesium Sulfate infusion 7despite adequate sensory block, and its occurrence is more fre-
quently observed during epidural anesthesia than spinal anes-
thesia [4]. It was necessary to evaluate the effect of IV NMDA
receptor antagonists in surgery with tourniquet under epidural
anesthesia.
In the current study using Mg sulfate infusion before inﬂa-
tion of tourniquet and continued until tourniquet deﬂation (in
arthroscopic knee surgery under epidural anesthesia) could
attenuate the hemodynamic response to tourniquet, and the
incidence of TIH reduced from 34.28% in the control group
to 8.57% in Mg group, and there was more stable intraopera-
tive hemodynamics (SBP, DBP and HR) in most of patients of
Mg group during the maintenance of tourniquet inﬂation,
while SBP and DBP increased signiﬁcantly in the control
group from 50 to 80 min (p< 0.001) and HR increased signif-
icantly from 60 to 80 min after tourniquet inﬂation
(p< 0.001). As the mechanism of NMDA receptor antago-
nism is the same in all NMDA receptor antagonists a study
by Yamashita and colleagues [21] showed that preoperative
oral dextromethorphan reduced the increase in arterial blood*
*
*
Figure 5 Mean ± SD of VAS score during the ﬁrst postoperat
group =Magnesium group). *p< 0.001 in Mg group compared to th
Please cite this article in press as: El Shal SM, Lotfy E Evaluation of eﬀect of intraven
arthroscopic knee surgery patients under epidural anesthesia, Egypt J Anaesth (2016pressure and heart rate during tourniquet inﬂation. Also Park
and colleagues [5] evaluated in their study -(on ketamine which
is NMDA receptor antagonist)- the effectiveness of preopera-
tive intravenous ketamine (0.1 mg/kg) to attenuate tourniquet
induced hypertension during inﬂation under general anesthesia
and proved that it was effective (28.6% in control group vs
7.1% in ketamine group). In another study conducted by Sat-
sumae et al. [8] it was detected that magnesium sulfate reduced
the tourniquet pain and hypertension in healthy volunteers. All
these ﬁndings proved that NMDA receptor antagonists could
attenuate TIH.
Tourniquet deﬂation was associated with a comparable sig-
niﬁcant reduction in mean SBP and DBP from baseline in both*
ive 24 h in the studied groups (n= 35 in each group) (Mg
e control group.
ous Magnesium Sulfate infusion on tourniquet induced hypertension and pain in
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Table 5 Postoperative serum magnesium level (mmol/L) in
the studied groups.
Magnesium group
n= 35
Control group
n= 35
Baseline
(preoperative)
1.22 ± 0.14 1.25 ± 0.12
6 h postoperative 1.74 ± 0.16** 1.09 ± 0.14
24 h postoperative 1.19 ± 0.18 1.14 ± 0.16
Data are mean ± SD.
P value < 0.05 is statistically signiﬁcant.
** P value < 0.001 in the Magnesium group compared to the
control group.
8 S.M. El Shal, E. Lotfygroups with increased HR at 1 and 5 min after deﬂation but
almost returned to the basal level at 10 and 30 min and no seri-
ous complications were observed due to the hypotension.
Abraham et al’s [2] study was in agreement with the current
study as they found a signiﬁcant decrease in both systolic
and diastolic blood pressures approximately in the ﬁrst three
minutes after tourniquet release. These changes may be due
to decrease in peripheral resistance caused by post ischemic
reactive hyperemia in the affected limb. Also Iwama et al.
[22] reported heart rate increase and blood pressure fall after
tourniquet deﬂation with combined epidural and propofol
anesthesia with preservation of spontaneous respiration.
As regards the onset of tourniquet pain, it was more pro-
longed in Mg group (71 ± 7 min) than in control group (48
± 8 min) with lower VAS score and intraoperative fentanyl
requirements in Mg group (p< 0.001). As the mechanism of
NMDA receptor antagonism is the same, a previous study
by Viscomi and co workers [23] demonstrated that another
one of NMDA receptor antagonists (ketamine) used as an
adjuvant in lidocaine-based intravenous regional anesthesia
(IVRA) could delay the onset of tourniquet pain. Also Sat-
sumae et al. [8] proved prolonged onset of tourniquet pain with
lower pain scores in Mg group compared to control group dur-
ing tourniquet inﬂation in healthy awake volunteers. The
results of the current study indicate that the frequency of
tourniquet pain is not related to the level of sensory anesthesia
as the level of sensory block at the onset of tourniquet pain
was comparable in the two groups, and this was in line with
previous study detected occurence of tourniquet pain in spite
of high sensory level [4].
As regards the postoperative analgesic effect of magnesium
sulfate the current study demonstrated that preoperative iv
magnesium infusion applied before tourniquet inﬂation signif-
icantly decreased postoperative VAS score, prolonged the time
to the ﬁrst analgesic request and reduced the postoperative
pethidine requirements. This may be due to potentiation of
the analgesic action of pethidine by magnesium through
NMDA receptor blockade. These ﬁndings of the current study
are in line with the reports of previous studies where magne-
sium was used as a possible adjuvant for intra- and postoper-
ative analgesia [13,14]. Dabbagh et al. [14] observed that
magnesium sulfate can serve as a supplementary analgesic pro-
viding signiﬁcant reduction in postoperative pain scores with
less postoperative morphine consumption in patients undergo-
ing orthopedic surgery under spinal anesthesia. Other studies
[13,24,25] reported the effectiveness of magnesium sulfate inPlease cite this article in press as: El Shal SM, Lotfy E Evaluation of eﬀect of intraven
arthroscopic knee surgery patients under epidural anesthesia, Egypt J Anaesth (201postoperative pain relief after orthopedic, and other types of
surgery where magnesium was supplied as continuous infusion
or repeated boluses. The results of the current study support
the previous studies which evaluated the effect of i.v infusion
of magnesium sulfate during spinal anesthesia on postopera-
tive pain. Kahraman and Eroglu [26] reported that the use of
i.v magnesium sulfate infusion during abdominal hysterectomy
(under spinal anesthesia) where 20 female patients received
magnesium sulfate 65 mg kg1 iv infusion in 250 mL 5% dex-
trose at 3.5 mL/min rate, while the control group (Group C,
n= 20) received at the same volume of saline during operation
in a double-blind randomized manner, the VAS scores were
lower in Group M than those in Group C postoperatively
(P< 0.01). Also, Agrawal et al. [27] concluded that the use
of intravenous magnesium with spinal anesthesia reduces
post-operative pain and analgesic consumption in patients
scheduled for elective orthopedic ﬁxation of fracture of long
bones of lower limbs under spinal anesthesia with an infusion
of (iv) magnesium sulfate 50 mg/kg/h over 15 min followed by
15 mg/kg/h until the end of the surgery (Group M) and 15 ml
of Normal Saline over 15 min followed by 100 ml/h until the
end of surgery (Group S). Need for ﬁrst analgesic requirement
was after 262.88 ± 21.11 min in group M and 193.25
± 17.74 min in the group S (P= 0.000). Mean dosage of tra-
madol needed in ﬁrst 24 h was less in group M (190
± 30.38 mg vs. 265 ± 48.30 mg, P= 0.000).
Also in a recent study by Taheri and co workers [28] mag-
nesium sulfate 50 mg kg1 in 100 mL of normal saline solu-
tion i.v was given as single-dose, just 15 min before induction
of anesthesia whereas patients in control group received
100 mL of 0.9% sodium chloride solution at the same time,
and they detected that postoperative pain score was lower in
magnesium group at 6, 12, and 24 h after the operations signif-
icantly. Pethidine requirement was signiﬁcantly lower in mag-
nesium group throughout 24 h after the surgeries and this is in
agreement with the current study. The same results were found
in the study by Agrawal et al. [29] who evaluated the effect of
i.v infusion of magnesium sulfate during spinal anesthesia, for
postoperative pain relief in patients undergoing lower segment
cesarean section. Also the study by Sousa et al. [30] proved
that intraoperative magnesium sulfate improves postoperative
pain control, acting as an opioid-sparing adjuvant.
On the other hand some researchers reported contradictory
results; they detected no beneﬁt of pre-treatment with IV mag-
nesium sulfate on decreasing post-operative pain and analgesic
consumption after abdominal hysterectomy and cesarean sec-
tion, and the precise reasons for this discrepancy are unknown
[31,32].
The mechanism of the postoperative analgesic effect of
magnesium is not clear, but interference with calcium channels
and NMDA receptors seems to play an important role. The
analgesic action of calcium channel blockers could be medi-
ated by an increase in the nociceptive threshold resulting from
interference with calcium inﬂux because calcium is important
for the release of neurotransmitters and other substances
shared in nociception and inﬂammation [24].
Magnesium causes a dose-dependent negative inotropic
effect, and in humans hemodynamic studies have shown that
it has a peripheral (predominantly arteriolar) vasodilatory
effect. After rapid infusion of 3 or 4 g of magnesium sulfate,
systolic arterial pressure decreased in relation to decreasedous Magnesium Sulfate infusion on tourniquet induced hypertension and pain in
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Evaluation of effect of intravenous Magnesium Sulfate infusion 9systemic vascular resistance [15]. In the present study, consid-
ering the negative inotropic effect of Mg, prehydration with
10 ml/kg of lactated Ringer’s solution was performed and
the Mg bolus dose was infused over 10 min, which is probably
why no signiﬁcant hypotension was encountered after admin-
istering the Mg bolus dose. The dose selected in the current
study, signiﬁcantly reduced pain without an episode of severe
hypotension and bradycardia. This ﬁnding best correlates with
results of Ozcan et al’s study [33] on patients undergoing tho-
racotomy. On the other hand El-Sharnouby and El-Sharnouby
[34] used magnesium sulfate 40 mg/kg over a period of 15 min
before induction and 15 mg/kg/h by continuous intraoperative
infusion, and they noticed more episodes of severe hypotension
may be related to the higher dose they used.
In the present study, Mg group showed signiﬁcantly lower
frequency of postoperative shivering (1 vs. 10). This ﬁnding
was consistent with the results of the study done by Wadhwa
and colleagues [35] who suggested that magnesium sulfate
infusion reduces the shivering threshold in humans. Shivering
increases discomfort and worsens postoperative pain, so reduc-
tion in shivering may decrease postoperative pain with higher
patients’ satisfaction [35].
After surgery, patients in the magnesium group showed
higher serum Mg concentrations after postoperative 6 h but
it returned to the basal level at 24 h. Magnesium toxicity
always appears at serum concentration of 2.5–5 mmol/liter
[36] which is much higher than the level detected in Mg group
in this study (1.74 ± 0.16 mmol/liter).
Ko and colleagues [31] have demonstrated an inverse rela-
tion between cerebrospinal ﬂuid (CSF) magnesium concentra-
tion and cumulative postoperative analgesic consumption. It is
suggested that the detected decrease in pain intensity or in
morphine consumption in many previous studies was not
due to a direct analgesic effect of magnesium but rather to
the prevention of hypomagnesemia which leads to prevention
of subsequent NMDA receptor activation [37].
The limitation of this study was the small sample size, and
the level of magnesium in CSF was not measured. Also post-
operative pain VAS was not assessed with movement.
Further studies are needed to be performed involving car-
diovascular disease patients, as TIH caused by tourniquet pain
represents a risk factor in patients with pre-existing essential
hypertension, ischemic cardiac disease and magnesium sulfate
may be useful in these patients. More studies should also be
done to evaluate the effect of spinal or epidural magnesium
sulfate on tourniquet pain and TIH.
5. Conclusion
In patients undergoing arthroscopic knee surgery under epidu-
ral anesthesia, IV magnesium sulfate in a dose of 30 mg/kg,
followed by 10 mg/kg/h infused intra-operatively before
tourniquet inﬂation compared to a control group could reduce
TIH, and tourniquet pain, postoperative pain with reduction
in intraoperative IV fentanyl and postoperative iv pethidine
requirements.
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